csirt@kutim:~/threat-intel/cve/CVE-2023-53536

Katalog CVE

CVSS 7.8 · High EPSS 0,16%

Kerentanan Use After Free pada linux kernel. Skor CVSS 3.1 7.8 (High) menurut NVD.

Deskripsi (NVD)

In the Linux kernel, the following vulnerability has been resolved: blk-crypto: make blk_crypto_evict_key() more robust If blk_crypto_evict_key() sees that the key is still in-use (due to a bug) or that ->keyslot_evict failed, it currently just returns while leaving the key linked into the keyslot management structures. However, blk_crypto_evict_key() is only called in contexts such as inode eviction where failure is not an option. So actually the caller proceeds with freeing the blk_crypto_key regardless of the return value of blk_crypto_evict_key(). These two assumptions don't match, and the result is that there can be a use-after-free in blk_crypto_reprogram_all_keys() after one of these errors occurs. (Note, these errors *shouldn't* happen; we're just talking about what happens if they do anyway.) Fix this by making blk_crypto_evict_key() unlink the key from the keyslot management structures even on failure. Also improve some comments.

Rincian

Terbit di NVD
4 Oktober 2025
Terakhir diubah
4 Agustus 2026
Status NVD
Modified
CVSS 3.1
7.8 (High), sumber NVD
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H · uraikan di kalkulator
Jenis kelemahan (CWE)
CWE-416: Use After Free
EPSS (30 hari)
0,16% peluang dieksploitasi; lebih tinggi dari 4,6% CVE lain

Produk dan versi terdampak

VendorProdukVersi terdampak
linux linux kernel Versi 5.8 hingga sebelum 5.10.180
linux linux kernel Versi 5.11 hingga sebelum 5.15.111
linux linux kernel Versi 5.16 hingga sebelum 6.1.28
linux linux kernel Versi 6.2 hingga sebelum 6.2.15
linux linux kernel Versi 6.3 hingga sebelum 6.3.2

> Data dari konfigurasi CPE di NVD.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:10 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.